Health Condition 1: M04-M04- Autoinflammatory syndromes
Conditions
Interventions
None listed
Sponsors
Reliance Life Sciences Pv Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of Rheumatoid Arthritis according to the criteria based on American College of Rheumatology (ACR)/ European League against Rheumatism (EULAR) classification criteria for Rheumatoid Arthritis according to routine clinical practice
Exclusion criteria
Exclusion criteria: 1. Pregnant women, nursing mothers or a planned pregnancy within 18 months of selection.Allergy to any of the excipients of adalimumab.Active TB. Also excluded are patients who have evidence of latent TB [evidence of tuberculosis based on standard hospital practice of TB screening]. Also excluded are patients with opportunistic infections including, but not limited to, evidence of active cytomegalovirus, active pneumocystis carinii, aspergillosis, or atypical mycobacterial infection, etc., within the previous 6 months.Patients with warnings / contraindications to AdaliRel® (see warnings in full prescribing information in Appendix )
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse events (AEs) and Serious Adverse Events (SAEs) up to 5 yearsTimepoint: Incidence of adverse events (AEs) and Serious Adverse Events (SAEs) up to 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse events (AEs) and Serious Adverse Events (SAEs) up to 5 yearsTimepoint: Incidence of adverse events (AEs) and Serious Adverse Events (SAEs) up to 5 years | — |
Countries
India
Contacts
Public ContactDr Jaysing Salve
Prakurti Care Hospital
Outcome results
None listed